DA
Detalus Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Buy |
+8,882
| New | +$215K | 0.06% | 160 |
|
|
2025
Q1 | – | Sell |
-7,706
| Closed | -$204K | – | 166 |
|
|
2024
Q4 | $204K | Sell |
7,706
-1,976
| -20% | -$52.4K | 0.07% | 142 |
|
|
2024
Q3 | $280K | Sell |
9,682
-15,362
| -61% | -$445K | 0.09% | 126 |
|
|
2024
Q2 | $701K | Sell |
25,044
-196
| -0.8% | -$5.48K | 0.24% | 57 |
|
|
2024
Q1 | $700K | Buy |
25,240
+242
| +1% | +$6.72K | 0.25% | 58 |
|
|
2023
Q4 | $720K | Sell |
24,998
-5,539
| -18% | -$159K | 0.29% | 54 |
|
|
2023
Q3 | $1.01M | Sell |
30,537
-139
| -0.5% | -$4.61K | 0.47% | 39 |
|
|
2023
Q2 | $1.13M | Sell |
30,676
-1,711
| -5% | -$62.8K | 0.5% | 39 |
|
|
2023
Q1 | $1.32M | Buy |
32,387
+87
| +0.3% | +$3.55K | 0.63% | 32 |
|
|
2022
Q4 | $1.66M | Sell |
32,300
-670
| -2% | -$34.3K | 0.81% | 27 |
|
|
2022
Q3 | $1.44M | Buy |
32,970
+42
| +0.1% | +$1.84K | 0.86% | 22 |
|
|
2022
Q2 | $1.73M | Sell |
32,928
-266
| -0.8% | -$13.9K | 1.01% | 17 |
|
|
2022
Q1 | $1.72M | Sell |
33,194
-2,734
| -8% | -$142K | 0.9% | 19 |
|
|
2021
Q4 | $2.12M | Sell |
35,928
-532
| -1% | -$31.4K | 1.02% | 18 |
|
|
2021
Q3 | $1.57M | Buy |
36,460
+3,310
| +10% | +$142K | 0.8% | 21 |
|
|
2021
Q2 | $1.3M | Buy |
33,150
+5,817
| +21% | +$228K | 0.69% | 24 |
|
|
2021
Q1 | $990K | Buy |
27,333
+277
| +1% | +$10K | 0.58% | 29 |
|
|
2020
Q4 | $996K | Sell |
27,056
-715
| -3% | -$26.3K | 0.63% | 23 |
|
|
2020
Q3 | $1.02M | Buy |
27,771
+354
| +1% | +$13K | 0.74% | 20 |
|
|
2020
Q2 | $897K | Buy |
27,417
+1,812
| +7% | +$59.3K | 0.69% | 18 |
|
|
2020
Q1 | $836K | Buy |
25,605
+4,801
| +23% | +$157K | 0.77% | 18 |
|
|
2019
Q4 | $815K | Buy |
+20,804
| New | +$815K | 0.59% | 28 |
|